Featured article

Roche and Causaly Webinar: AI for smarter portfolio management - Moving beyond serendipity in early R&D

Pharmaceutical research is inherently risky and failed or discontinued projects are an inevitable part of the R&D process. A key...

Announcing Causaly Connect: A virtual meeting of Life Science leaders

On October 4-6, Life Science professionals from across the globe will meet virtually for Causaly Connect – an insightful series of...

Why poor target validation is costing pharmaceutical businesses millions

It has been well documented that only 1 out of 10 compounds that enter clinical trials makes it to market¹. That is an astonishing 90%...

  • Point of View

Watch Causaly’s panel discussion from Discovery Europe

On June 9th – 10th 2022, over 400 pharma leaders came to Berlin to take part in Discovery Europe...

  • General

Webinar - Knowledge discovery reimagined: finding new hypotheses with Causaly Cloud

It is well recognized among scientists that target selection can improve clinical trial success rates (1). Being able to stay up to date...

  • use case

Sign up for Causaly newsletter